New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 9, 2013
07:08 EDTIRWDNothing alarming in Ironwood Linzess safety reports, says Cantor
After analyzing safety reports to the FDA for Ironwood's Linzess drug for most of the first ten months of the year, Cantor reports that the FDA has not indicated that the Linzess label may require additional safety language. The firm continues to expect the company's revenue to rebound starting in 2H14 and keeps a Hold rating on the shares.
News For IRWD From The Last 14 Days
Check below for free stories on IRWD the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for IRWD

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use